Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Isoproterenol and Potassium

supplement:

Potassium

Research Papers that Mention the Interaction

Isoprenaline and salbutamol decreased plasma potassium dose-dependently.
European heart journal  •  1983  |  View Paper
Isoproterenol (4 × 10 −10-4 × 10 −6 M) concentration dependently relaxed the strips under potassium contracture , but a high dose (4 × 10−5 M) constricted them.
Journal of cardiovascular pharmacology  •  1982  |  View Paper
Using a triple lumen perfusion technique we have demonstrated that intravenous isoproterenol significantly increased absorption of sodium, chloride, and water in both the jejunum and ileum, and of potassium in the ileum.
Gastroenterology  •  1981  |  View Paper
Sustained isoproterenol exposure decreased IKs density (whole cell patch clamp) by 58% (P<0.0001), with corresponding decreases in potassium voltage-gated channel subfamily E member 1 (KCNE1) mRNA and membrane protein expression (by 45% and 51%, respectively).
Circulation research  •  2014  |  View Paper
In this model of mucosal injury, pretreatment with prostaglandin E2 or isoproterenol significantly and dose dependently decreased luminal hydrogen loss, potassium gain , and DNA accumulation in both shocked and normotensive animals.
The Journal of surgical research  •  1994  |  View Paper
In conscious rabbits the intravenous infusion of adrenaline (0.3 microgram kg-1 min-1), noradrenaline (1 microgram kg-1 min-1) or isoprenaline (1.25 micrograms kg-1 min-1) caused a significant decrease in plasma potassium levels.
Journal of autonomic pharmacology  •  1993  |  View Paper
Also, isoprenaline was less potent and efficacious on aortic strips contracted with potassium than on strips contracted with phenylephrine.
Developmental pharmacology and therapeutics  •  1991  |  View Paper
Isoproterenol at the dosage of 5 μg/kg body wt significantly inhibited net influx of potassium in both the RES rat and normal rat.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine  •  1989  |  View Paper
Isoproterenol (0.6-0.8 microgram/min), a nonspecific beta-agonist, reduced coronary sinus potassium concentration transiently to a nadir of 0.28 (0.15-0.43) mM (median and 95% confidence interval) below control values (n = 12).
Circulation research  •  1987  |  View Paper
Spontaneous potassium release from the slices was significantly inhibited by isoproterenol at concentrations above 10(-6) M. This isoproterenol effect was completely abolished in the presence of propranolol (10(-5) M) and ouabain (10(-3) M) and was abolished during Na+-exclusion from the incubation medium.
The stimulatory effect of isoproterenol on the Na+, K+-ATPase exhibited a strong correlation with the inhibition of potassium release on each dose of isoproterenol.
These results suggest that the inhibitory effect of isoproterenol on potassium release is clearly derived from the elevated Na+, K+-ATPase activity and that it may in part be mediated by cyclic AMP.
Japanese journal of pharmacology  •  1985  |  View Paper
Show More